Notably, Bourefis et al. found that using a combination of HSP27 and menin serum levels was more accurate for predicting prostate cancer aggressiveness and mortality than PSA [331], suggesting that high serum menin levels may be useful for identifying individuals with prostate cancer who may be at increased risk for aggressive disease and mortality. The gene discussed is MEN1; the disease is Familial prostate cancer.